PSMA6

PSMA6 encodes an alpha-type subunit of the 20S proteasome catalytic core, originally identified as the prosomal protein p27K/PROS27 within the prosome–MCP–proteasome alpha sub-family (PMID:7681138). The protein carries an RNA-binding consensus sequence, and a PROS27 fusion protein binds a discrete ~120-nucleotide RNA species from total cellular RNA, marking it as an RNA-associated component of the particle (PMID:7681138). As a constituent of the 20S core, PSMA6 acts as a positive regulator of NF-κB signaling: its depletion stabilizes phosphorylated IκB and reduces NF-κB activation, linking the subunit to proteasomal degradation of phospho-IκB (PMID:16845397). Loss-of-function studies establish PSMA6 as essential for cancer cell survival — silencing induces apoptosis or G2/M arrest selectively in lung cancer cells (PMID:28165654) and impairs spheroid formation and viability in pancreatic ductal adenocarcinoma models, where proteasome inhibition by bortezomib is especially cytotoxic (PMID:30898113). Beyond these roles in proteasomal degradation, NF-κB regulation, and cancer cell viability, no further mechanistic detail of PSMA6 catalytic chemistry or assembly has been characterized in the available corpus.

1. 1993 Medium

   Established the molecular identity of PSMA6 as an alpha-type prosome/proteasome subunit and uncovered an unexpected RNA-binding property, framing it as more than a passive structural component.

   Evidence cDNA cloning, sequence analysis with chromosomal mapping, and an RNA-binding assay using a PROS27/β-galactosidase fusion against HeLa RNA

   PMID:7681138

   Open questions at the time

   • The functional significance of the ~120-nt RNA interaction is undefined
   • No structural placement of the subunit within the assembled 20S core
   • RNA-binding shown only with a fusion construct, not full-length endogenous protein
2. 2006 Medium

   Connected PSMA6 to a defined signaling output by showing the proteasome subunit drives NF-κB activation through degradation of phosphorylated IκB, with a regulatory SNP modulating its expression.

   Evidence Reporter/transcription assay of a 5'UTR SNP plus siRNA knockdown measuring phospho-IκB stabilization and NF-κB activity

   PMID:16845397

   Open questions at the time

   • Does not establish whether PSMA6 acts via its catalytic core role or a distinct mechanism
   • No direct biochemical demonstration of phospho-IκB processing by PSMA6-containing proteasomes
   • SNP-to-phenotype causality in vivo not resolved
3. 2010 Low

   Linked PSMA6 abundance to a disease context by showing reduced expression in diabetic renal tissue, raising the possibility of altered proteasomal capacity in nephropathy.

   Evidence 2D-gel proteomics of high-glucose mesangial cells with MALDI-TOF identification and Western blot validation in two diabetic rat models

   PMID:20651835

   Open questions at the time

   • Purely descriptive — no functional mechanism established
   • Correlation between PSMA6 loss and renal pathology not demonstrated causally
   • Single lab, model-organism observation
4. 2019 Medium

   Demonstrated that PSMA6 is a survival-essential gene across cancer types, establishing it as a vulnerability whose loss triggers apoptosis/cell-cycle arrest and sensitizes cells to proteasome inhibition.

   Evidence Semi-genome-wide shRNA screen in lung cancer with apoptosis/cell-cycle readouts; genome-wide CRISPR negative-selection screen in PDAC with siRNA deconvolution, spheroid assays, and bortezomib cytotoxicity

   PMID:28165654 PMID:30898113

   Open questions at the time

   • Selectivity over normal cells shown in limited models
   • Whether essentiality reflects general proteasome dependence or a PSMA6-specific function is unresolved
   • No mechanistic link between essentiality and the NF-κB/RNA-binding activities

• The biochemical role of PSMA6's RNA-binding activity and its precise contribution to substrate selection within the 20S core remain unresolved.
• No identified physiological RNA ligand or its function
• No structural model of PSMA6 within the assembled proteasome from the corpus
• Mechanism connecting subunit-level perturbation to NF-κB and cancer-cell phenotypes not directly defined